Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ471,5472-0,42
KB5865871,73
PKN53,4253,44-0,89
Msft0,64
Nokia3,4143,421,11
IBM0,12
Daimler AG56,5556,570,89
PFE1,92
27.11.2020 23:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 25.11.2020 23:20:00
MusclePharm Corp, Ordinary, US 'Other OTC' and Grey Market (MSLPD.PK, US Other OTC (Pink Sheets))
Závěr k 25.11.2020 Změna (%) Změna (USD) Objem obchodů (ks)
0,23 -4,17 -0,01 1 250
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 30.11.2020
Popis společnosti
Obecné informace
Název společnostiMusclePharm Corp
TickerMSLP
Kmenové akcie:Ordinary Shares
RICMSLP.PK
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky30.09.2020
Počet zaměstnanců k 31.12.2019 45
Akcie v oběhu k 16.11.2020 33 130 039
MěnaUSD
Kontaktní informace
Ulice4400 W Vanowen St
MěstoBURBANK
PSČ91505-1134
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon13 033 966 100

Business Summary: MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company's portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman's lifestyle utilizing ingredients that cover the range of busy women's needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.
Financial Summary: BRIEF: For the nine months ended 30 September 2020,MusclePharm Corp revenues decreased 21% to $49.3M. Netincome totaled $365K vs. loss of $15.5M. Revenues reflectUnited States (Country) segment decrease of 21% to $35.4M,international segment decrease of 20% to $13.9M. Net Incomereflects Advertising and promotion decrease of 83% to $362K(expense), Interest expense, related party decrease of 85%to $228K (expense).
Odvětvová klasifikace
TRBC2012Special Foods & Welbeing Products
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
SICPharmaceutical Preparations
SICPharmaceutical Preparations
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 30.11.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRyan Drexler4917.11.201724.06.2015
Chief Financial OfficerAllen Sciarillo5520.04.202020.04.2020